About Us-Baheal

Baheal Pharma Group

Baheal Pharma Group is a health industry group which is driven by scientific and technical innovation. The Group is based on its commercialization capabilities, with a core focus on asset accretion, and with innovative incubation as its characteristics. Its key business include a health brand commercialization platform, investment and incubation for innovative achievements. The Group is dedicated to providing better health products and services for all society, while also providing practical optimization for the medical field.

Brand Commercialization Platform

As China’s leading health brand commercialization platform, Baheal Medical (stock code: 301015) spares no effort in building brand highways and providing upstream industrial enterprises with omni-channel solutions that improve their operational efficiency and promote the standardized development of the industry, by utilizing our core capabilities in category insight and brand operation, digital marketing and ecological organization collaboration. Over more than ten years of unremitting efforts, we have established a robust marketing network and stable cooperative relationships with hundreds of upstream companies, in addition to incubating multiple leading brands.
Innovation Incubation

Centering on our development strategy of commercial breakthroughs and ecological innovation, Baheal Pharma Group strives to invest and incubate innovative achievements based on its commercialization platform. By focusing on the three value channels of innovative medicines, high-end medical devices, and technical transformation platform, the Group continues to culture innovations with real clinical application value to build an industrial cluster for medical, health science, and technological innovation by providing capital, management support, marketing promotion, and other resources and elements configured for innovative enterprises，strive forward to the development of an ecological Big Pharma.

一级标题

一级标题